NMR-based metabonomics in toxicology research

Metabolome Analyses: Strategies for Systems Biology

Volumn , Issue , 2005, Pages 159-171

  Schnackenberg, Laura K ^a   Beger, Richard D ^a   Dragan, Yvonne P ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33847378349     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-25240-1_10     Document Type: Chapter

References (30)

1. Aardema MJ, MacGregor JT. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "omics" technologies. Mutat. Res., 499:13-25 (2002).
2. Badger TM et al. Cyclic expression of class I alcohol dehydrogenase in male rats treated with ethanol. Biochem. Biophys. Res. Commun., 21A:684-688 (2000).
3. 1H NMR spectroscopic analysis of urine. J. Inherit. Metab. Dis., 22:297-301 (1999).
4. 1H-NMR-based metabonomics. Nat. Med., 8:1439-1445 (2002).
5. 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst, 128:32-36 (2003).
6. Coen M et al. Integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem. Res. Tox., 16:295-303 (2003).
7. Coen M et al. Integrated application of transcriptomics and metabonomics yields new insight into the due to paracetamol in the mouse. J. Pharm. Biomed. Anal., 35:93-105 (2004).
8. Fiehn O. Metabolomics-the link between genotypes and phenotypes. Plant Mol. Biol., 48:155-171 (2002).
9. Foxall P J D et al. NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int., 43:234-245 (1993).
10. 1H NMR and magic angle spinning NMR spectroscopic investigation of the biochemical effects of 2-bromoethanamine in intact renal and hepatic tissue. Magn. Reson. Med., 45:781-790 (2000).
11. 1H NMR spectroscopy. Biochim. Biophys. Acta, 1619:151-158 (2003).
12. 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. Anal. Biochem., 220:284-296 (1994).
13. 1H NMR spectroscopy characterization of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutatric aciduria and maple syrup urine disease. J. Pharm. Biomed. Anal, 15:1647-1657 (1997).
14. 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed., 11:235-44 (1998).
15. Holmes E et al. Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem. Res. Toxicol., 13:471-478 (2000).
16. 1H NMR-based metabonomic urinalysis. Chem. Res. Toxicol., 15:1380-1386 (2002).
17. Keun HC et al. Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles. Chem. Res. Toxicol., 17:579-587 (2004).
18. Lindon JC et al. Contemporary issues in toxicology: The role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharm., 187:137-146 (2003)
19. Lynch MJ et al. Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions. J. Pharm. Biomed. Anal, 12:5-19 (1994).
20. Nicholson JK, Wilson ID. High-resolution proton NMR spectroscopy of biological fluids. Prog Nucl. Mag. Res. Sp., 21:449-501 (1989).
21. 13C NMR spectroscopy of human blood plasma. Anal. Chem., 67:793-811 (1995).
22. Nicholson JK, Lindon JC, Holmes H. "Metabonomic": understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29:1181-1189 (1999).
23. Nicholson JK et al. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov., 1:153-161 (2002).
24. Nicholson JK, Wilson ID. Understanding "Global" Systems Biology: Metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov., 2:668-676 (2003).
25. Plumb RS et al. Metabonomic analysis of mouse urine by liquid-chromatography-time of flight mass spectrometry (LC-TOFMS): detection of strain, diurnal and gender differences. Analyst, 128:819-823 (2002).
26. Robertson DG et al. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol. Sci., 57:326-337 (2000).
27. Rosenberg B. Platinum complexes for the treatment of cancer. Interdiscipl. Sci. Rev., 3:134-147 (1978).
28. Timbrell JA, Waterfield CJ, Draper RP. Use of urinary taurine and creatine as biomarkers of organ dysfunction and metabolic perturbations. Comp. Haematol. Int., 5:112-119 (1995).
29. 1H NMR spectroscopy of intact liver and kidney: optimization of sample preparation procedures and biochemical stability of tissue during spectral acquisition. Anal. Biochem., 282:16-23 (2000).
30. Waters NJ et al. NMR and pattern recognition studies on the time-related metabolic effects of α-Naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach. Chem. Res. Toxicol., 14:1401-1412 (2001).